Skip to main content
Premium Trial:

Request an Annual Quote

Agendia Partners With GeneCast to Launch Tests in China

NEW YORK (GenomeWeb) — Agendia today announced a partnership with GeneCast Biotechnology to make its breast cancer tests available in China.

Under the terms of the deal, Beijing-based GeneCast has the exclusive right to market Agendia's MammaPrint and BluePrint tests to Chinese customers. Local physicians will be able to send patient samples to GeneCast's oncology laboratory for testing, the firms said.

Franklin Libenson, senior VP of strategic marketing and marketing development for Amsterdam-based Agendia, said that China is a "significant market with an urgent need" for MammaPrint and BluePrint.

MammaPrint analyzes 70 genes associated with breast cancer recurrence to provide a low or high risk of cancer recurrence, enabling physicians to decide which individuals can forgo chemotherapy. Agendia's BluePrint test interrogates 80 genes and classifies a patient's breast cancer into one of four functional molecular subtypes.

Agendia, which maintains a US office in Irvine, California, has been moving to a decentralized testing model in recent months, and inked a marketing agreement with Singapore-based Angsana Molecular & Diagnostics Laboratory covering multiple Southeast Asian countries in May.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.